Cargando…
白消安联合增量氟达拉滨为主预处理方案进行异基因造血干细胞移植治疗MDS和MDS-AML的临床研究
OBJECTIVE: To investigate the safety and efficacy of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for myelodysplastic syndrome (MDS) and secondary acute myelogenous leukemia (MDS-AML) using conditioning regimen with busulfan (Bu) and increased-dose of fludarabine (ID-Flu). METHODS:...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343060/ https://www.ncbi.nlm.nih.gov/pubmed/26134011 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.06.006 |
Ejemplares similares
-
应用白消安联合氟达拉滨预处理方案建立小鼠半相合骨髓移植移植物抗宿主病模型
Publicado: (2015) -
氟达拉滨和环磷酰胺联合利妥昔单抗(FCR方案)一线治疗慢性淋巴细胞白血病43例临床分析
Publicado: (2021) -
大剂量美法仑与环磷酰胺、依托泊苷联合白消安预处理方案在多发性骨髓瘤自体造血干细胞移植中的比较
Publicado: (2019) -
不同胸外科医生主刀进行肺癌手术的患者生存差异分析
Publicado: (2018) -
吞咽困难为主诉的原发性支气管肺癌1例报道
Publicado: (2011)